SCTCi045-A-1

iPS24-00085 clE3, fIPS_DM1Rescue_P3 clE3

The cell line is not validated yet.

General

Cell Line

hPSCreg name SCTCi045-A-1
Cite as:
SCTCi045-A-1
Alternative name(s)
iPS24-00085 clE3, fIPS_DM1Rescue_P3 clE3
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
SCTCi045-A
(iPS21-00148 cl1, fIPS_DM1_P3 cl1)
Donor diseases:
myotonic dystrophy type 1
SCTCi044-A-1
(iPS24-00086 clB5, fiPS_DM1Rescue_P2 clB5)
Donor diseases:
myotonic dystrophy type 1
SCTCi043-A-1
(iPS23-00086 clE2, fIPS_DM1Rescue_P1 clE2)
Donor diseases:
myotonic dystrophy type 1
SCVIi137-A
(SCVI 770)
Donor diseases:
myotonic dystrophy type 1
CENSOi008-A
(FB77R2c3, CENSOi260)
Donor's gene variants:
DMPK, DMPK
Donor diseases:
myotonic dystrophy type 1
RGIe061-A
(SI-153)
Donor diseases:
myotonic dystrophy type 1
SCTCi044-A
(fIPS_DM1_P2 cl1, iPS19-00073 cl1)
Donor diseases:
myotonic dystrophy type 1
CBRCULi012-A
(GM04601 clone 21, GM04601-21)
Donor diseases:
myotonic dystrophy type 1
CBRCULi013-A
(GM04602-2, GM04602 clone 2)
Donor diseases:
myotonic dystrophy type 1
SCVIi134-A
(SCVI 692)
Donor diseases:
myotonic dystrophy type 1
CBRCULi003-A
(59-0944-2)
Donor diseases:
myotonic dystrophy type 1
CBRCULi018-A
(91-2032-7)
Donor diseases:
myotonic dystrophy type 1
CBRCULi019-A
(19-1741-2)
Donor diseases:
myotonic dystrophy type 1
CBRCULi020-A
(79-1761-15)
Donor diseases:
myotonic dystrophy type 1
CBRCULi007-A
(14-0730-1)
Donor diseases:
myotonic dystrophy type 1
VUBe003-A
(VUB03_DM1)
Donor diseases:
myotonic dystrophy type 1
RGIe057-A
(SI-148)
Donor diseases:
myotonic dystrophy type 1
CHUQi001-A
(522-2666-2, SAMEA104271492)
Donor diseases:
myotonic dystrophy type 1
SCTCi043-A
(fIPS_DM1_P1 cl1, iPS19-00072 cl1)
Donor diseases:
myotonic dystrophy type 1
HADe001-A
(HAD 1)
Donor diseases:
myotonic dystrophy type 1
CBRCULi002-A
(19-1035-10)
Donor diseases:
myotonic dystrophy type 1
HADe006-A
(HAD 6)
Donor diseases:
myotonic dystrophy type 1
CBRCULi004-A
(79-1660-2)
Donor diseases:
myotonic dystrophy type 1
CBRCULi005-A
(91-3158-1)
Donor diseases:
myotonic dystrophy type 1
CBRCULi015-A
(GM23375-1, GM23375 clone 1)
Donor's gene variants:
DMPK – DM1 protein kinase, DMPK – DM1 protein kinase
Donor diseases:
Congenital Myotonic Dystrophy
ZZUi015-A
(ZZU-iPS-DM1-002)
Donor diseases:
myotonic dystrophy type 1
KCLe014-A
(KCL018_MD1)
Donor diseases:
myotonic dystrophy type 1
Last update 15th December 2025
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Radboudumc - Department of Human Genetics (RMCGEN)

External Databases

BioSamples SAMEA119974288

General Information

* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information

Sex female

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • DM1
  • DMPK myotonic dystrophy
  • MD1
  • Steinert disease
  • Steinert myotonic dystrophy syndrome
  • Steinert syndrome
  • dystrophia myotonica
  • myotonic dystrophy caused by mutation in DMPK
  • myotonic dystrophy of Steinert
  • myotonic dystrophy type 1
  • Steinert myotonic dystrophy
  • Steinert's disease
  • dystrophia myotonica 1
  • dystrophia myotonica type 1
  • myotonic dystrophy 1
  • Myotonic Dystrophy
show more synonyms

External Databases (Donor)

BioSamples SAMEA119974285

Ethics

Also have a look at the ethics information for the parental line SCTCi045-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line SCTCi045-A.

Reprogramming method

Vector type Integrating
Vector Virus (Lentivirus)
Genes
Is the used vector excisable?
No
Absence of reprogramming vector(s)?
No
Reprogramming vectors silenced?
Yes
Methods used
PCR, RT-PCR
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 20 %
CO2 Concentration 5 %
Medium Essential 8™ Flex

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
SOX2
Yes
NANOG
Yes
SSEA-4
Yes
TRA 1-81
Yes
DNMT3B
Yes
LIN28A
Yes
Marker Present Absent
mCpG
OCT4
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
FOXA2
Yes
SOX17
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
HAND1
Yes
TBXT (BRACHYURY)
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
PAX6
Yes
NCAM1
Yes

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46,XX
Passage number: 15

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Synonyms
  • DM1
  • DMPK myotonic dystrophy
  • MD1
  • Steinert disease
  • Steinert myotonic dystrophy syndrome
  • Steinert syndrome
  • dystrophia myotonica
  • myotonic dystrophy caused by mutation in DMPK
  • myotonic dystrophy of Steinert
  • myotonic dystrophy type 1
  • Steinert myotonic dystrophy
  • Steinert's disease
  • dystrophia myotonica 1
  • dystrophia myotonica type 1
  • myotonic dystrophy 1
  • Myotonic Dystrophy
show more synonyms
Genetic modifications
Isogenic modification
Homozygous
Non homologous endjoining of a dual CRISPR strategy excising the mutated expanded repeat and the unaffected allele.
Changed